Moreover, in the murine APL model, ROS-inducers lead to PML/RARα degradation, regression of the disease and/or longer survival47; our prolonged survival of PML/RARα mice after EGCG treatment corroborates these assumption. Here, RARA is linked to acute promyelocytic leukemia.